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Abstract: Where do new research questions come from? This is at best only partially taught in 
courses or textbooks about clinical or epidemiological research. Methods are taught under the 
assumption that a researcher already knows the research question and knows which methods will 
fit that question. Similarly, the real complexity of the thought processes that lead to a scientific 
undertaking is almost never described in published papers. In this paper, we first discuss how 
to get an idea that is worth researching. We describe sources of new ideas and how to foster a 
creative attitude by “cultivating your thoughts”. Only a few of these ideas will make it into a 
study. Next, we describe how to sharpen and focus a research question so that a study becomes 
feasible and a valid test of the underlying idea. To do this, the idea needs to be “pruned”. Pruning 
a research question means cutting away anything that is unnecessary, so that only the essence 
remains. This includes determining both the latent and the stated objectives, specific pruning 
questions, and the use of specific schemes to structure reasoning. After this, the following steps 
include preparation of a brief protocol, conduct of a pilot study, and writing a draft of the paper 
including draft tables. Then you are ready to carry out your research.
Keywords: study design, writing a paper, research questions
Introduction
How do you get an idea for a study? How do you turn your idea into a testable 
hypothesis, and turn this into an appropriate and feasible study design? This is usu-
ally at best only partially taught in epidemiology courses. Most courses and textbooks 
assume that you know your research question and the general methods that you will 
need to answer it. Somehow it is assumed that you can readily translate your idea into 
a specific framework, such as the PICO framework (Patient, Intervention, Control 
or Comparison, Outcome)1 or the FINER framework (Feasible, Interesting, Novel, 
Ethical, and Relevant)2 or that you can fit it into counterfactual reasoning.3 However, 
before describing your project in one of these frameworks, you first need to have an 
idea for your study and think about it in general terms: why you might do a study and 
how you might do a study.
This paper considers the complex process of having ideas, keeping track of them, 
turning them into studies, trying them out in pilot studies, and writing a draft paper 
before you finally embark on your study. 
The paper is intended for novice researchers in clinical or public health epidemi-
ology. It is not intended to be a comprehensive literature review about creativity, nor 
a sociology or philosophical treatise about why scientists get particular ideas (and 
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not other ideas). It is based on our personal experience of 
(a combined) 70+ epidemiologic research-years. We have 
worked on very different topics, mostly on opposite sides of 
the globe, yet found that our experiences are quite similar. 
The fact that these issues are rarely covered in epidemiology 
courses has provided motivation to reflect on our experience. 
Getting new ideas 
So how do you get an idea? How some juxtaposition of neural 
patterns in our brain suddenly creates a new idea is a process 
that we are far from understanding. According to Karl Pop-
per, the origin of new ideas does not matter; the only thing of 
interest is to devise how to test them.4 Over the past decades, 
the literature has been enriched with new ideas about “being 
creative” in science – as witnessed in the book Innovation 
Generation by Ness.5 
In the present paper, we will not cover the literature about 
creativity and discovery in depth, but we will discuss the 
issues that we consider relevant to epidemiologic research. 
We will first consider the more general principles. 
The real complexity of the thought processes that lead to a 
scientific undertaking is almost never described in published 
papers. Immunologist Medawar claimed that in this respect 
almost all scientific papers may be a fraud – not in the sense 
that scientists deliberately produce misleading data, but in the 
sense that the real thought processes that lead to the data and 
conclusions are not mentioned.6 Scientists tell us about their 
real thought processes in memoirs, inaugural, or valedictory 
lectures – which is why these are so much more interesting 
than “standard” papers or presentations. 
What strikes our minds: regularities or 
anomalies?
All sciences study a particular “object of knowledge” (eg, 
“matter”, “life”). Ideas come from experience and previous 
knowledge or facts about this object of knowledge, although 
this knowledge is always filtered through the perspective of 
one or more theories.7 Epidemiology studies the distribution 
and determinants of disease in human populations,8 and 
epidemiological ideas arise from observing and thinking 
about populations.9 These could be clinical populations (ie, 
clinical experience, sometimes involving just a few patients), 
exposure-based populations (eg, workers exposed to a par-
ticular chemical), or general populations (geographically 
defined or sociologically defined). Whatever the population 
we are interested in, ideas come from observing either regu-
larities or anomalies. 
The observation of regularities (“induction”) is a common 
origin of new ideas.4,10–13 Philosopher David Hume described 
“Induction” as: regularly seeing two things happening in suc-
cession (like pushing a switch and a light going on) leads to 
suspicions of causality. As he pointed out, causality can never 
be proven by the mere observation of “constant conjunctions”, 
but observing regularities can start our train of thought.12 
An anomaly (or irregularity) strikes our mind, because it 
defies our expectations. The regularity that we expected was our 
“hypothesis” (even if it was not really explicitly formulated); 
the anomaly is a “refutation”.4,13 It forces us to think about other 
explanations, and these lead to new hypotheses that we then try 
to test. Thus, scientists do not usually start from hypotheses that 
are nicely formulated “out of the blue”, but instead start from 
previous knowledge and experience; when they are challenged 
by anomalies, scientists seek new explanations.14 
An interesting way to discover anomalies is to enter a new 
field of research; since you have other background experience 
than the people already in the field, you see things that they 
take for granted but that strike you as odd – at the same time, 
you may also see new explanations for these anomalies. One of 
the pioneers of clinical epidemiology, Sackett, once wrote that 
scientists should “retire” from a field as soon as they become 
“experts”.15 When you are too long in a field, you will no longer 
see the anomalies, and you may even obstruct newcomers with 
new explanations. Of course, there are differences between 
scientists: some roam across various fields and others stick to 
a problem area that they explore with increasing depth – then 
the increasing depth and the new techniques that one needs for 
advancing one’s thoughts will be like a “new field”. 
Taxonomies of discovery
Few researchers have listed the different ways in which one 
can arrive at new ideas, that is, lists of ways of discovery. We 
will present two of them – which have very different origins 
but remarkable similarities. Several examples of studies cor-
responding to items on these two lists are given in Appendix 
Examples A1–A10.
Sources for new ideas about health care evaluation were 
described by Crombie and Davies in the chapter “Developing 
the research question” of their book on Research in Health 
Care that reflects a UK public health experience.16
•	 “Review existing practice […] the current organisation and 
delivery of health care is not as good as it could be […]”
•	 “Challenge accepted ideas […] much of health care is 
based on accepted practice rather than research evidence 
[…]” (Appendix Example A3)
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•	 “Look for conflicting views […] which indicate either that 
there is not enough evidence, or that some practitioners 
are misinformed”
•	 “Investigate geographical variation […] reflecting on the 
reasons [for geographical variation] can be a fruitful source 
of research questions […]” (Appendix Example A6)
•	 “Identify Cinderella topics […] important areas of health 
care are often overlooked […]”
•	 “Let loose the imagination  […] look for wild or impos-
sible ideas […] free the mind from the constraints of 
conventional wisdom […].”
A taxonomy for sources of clinical research questions 
about medical care and clinical problems was proposed by 
Hulley and Cummings, in the context of clinical research 
in the US:2 
• “Build on experience;” your own experience, that of 
close colleagues with whom you can freely discuss your 
research ideas, and that of a good mentor, because young 
researchers might not yet have much experience, “An 
essential strategy for a young investigator is to apprentice 
himself to an experienced senior scientist who has the 
time and interest to work with him regularly.”
•	 “Be alert to new ideas”
	 By harvesting “the medical literature and attending 
journal clubs, national and international meetings, 
seeking informal conversations with other scientists 
and colleagues”
	 “A sceptical attitude about prevailing beliefs can 
stimulate good research questions” 
	 Be alert to “careful observation of patients, which has 
historically been one of the major sources of descrip-
tive studies” (Appendix Examples A1 and A2)
	 Your experiences in teaching; having to explain some-
thing may make you aware of gaps in your knowledge; 
questions by patients and colleagues may similarly 
identify things that we do not fully understand or ignore
•	 “Keep the imagination roaming […]” by a mixture of cre-
ativity and tenacity; “put an unresolved question clearly 
in view and turn on the mental switch that lets the mind 
run freely toward it”.
A special mention needs to be made about the last 
categories of both the lists: “Let loose the imagination” 
and “Keep the imagination roaming”. These are especially 
important to find innovative solutions. In many situations 
wherein you cannot do a perfect study and you run a grave 
danger of potential confounding or bias, it helps to “get 
deeply immersed”: to understand the problem biologically, 
clinically, socially, organizationally, and environmentally 
will help you to think about what is happening, why it is 
happening, and whether you can find situations in which 
the potential confounders or biases do not exist or exists 
in reverse. You should forget formal designs and think out 
of the box: you will find instances of studies that mutually 
reinforce each other and may even arrive at formulating 
new designs or analytic solutions (see Appendix Examples 
A7–A10). 
Keeping track of your ideas
It is not only important to have good ideas but also impor-
tant to develop them. Researchers who work in labora-
tories have the habit of keeping “lab logs”. They write 
down briefly the results of an experiment, note why they 
think it went wrong, and how they will perform the next 
experiment. This permits them to trace how they changed 
the experiments or even the content and the direction of 
their research. We should do the same in epidemiologic 
and clinical research, particularly in the stage of creating 
new ideas. Such notes about ideas can include not only 
hypotheses and views or results by others but also drawing 
directed acyclic graphs (DAGs) (see “Intermezzo: specific 
schemes to structure reasoning” section) to make the causal 
structures of ideas clear.
The greatest minds kept track of their thoughts. Charles 
Darwin’s notebooks document his ideas, his observations, 
his readings, and new theories and facts that struck him.17 
For example, Darwin noted a story that he heard from his 
father, a medical practitioner. His father recounted that he 
had been struck by one of his patients’ ways of expressing 
himself, because he had attended a parent of the patient who 
had had the same mannerisms – even though the parent had 
died when the patient was still an infant. Remarks like these 
still have relevance today when we think about the heredity 
and evolution of behavior. 
The sociologist C Wright Mills carried the description of 
the process one step further in the appendix of his book on The 
Sociological Imagination.18 He encourages young sociologists 
to set up a file of stacked cards to keep track of “[…] personal 
experience and professional activities, studies underway and 
studies planned […]” which “[…] encourages you to capture 
‘fringe thoughts’: various ideas which may be by-products of 
everyday life, stretches of conversations […]”. These notes are 
continuously reshuffled, regrouped under new headings, and 
pondered. Mills denounced the habit of most (social) scientists 
who feel the need to write about their plans only when they are 
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going to apply for a grant. He thought that scientists should 
continually work with their file of ideas and regularly take stock 
of how these have evolved.
Such strategies are still relevant today, even if our “logs” are 
kept in electronic form, particularly because grant writing has 
become more demanding, hectic, and time-consuming. From 
such files, new research projects are born: while your ideas 
gradually develop, you keep wondering what data you might 
need to prove a certain proposition, and how you might get 
those data in the easiest way possible. Often, ideas are reshuffled 
and regrouped under new headings. A new observation, a new 
piece of literature may make old ones fall into place, or there 
may suddenly be a new opportunity to work out an old idea. 
A complementary advice recently came in a blog from a 
contemporary sociologist, Aldrich: his advice is to “Write as 
if you don’t have the data”, that is, to write “[…] the literature 
review and planning phase of a project, preferably before it 
has been locked into a specific research design”.19
The role of emotions
Underlying the discovery process, there are often two emo-
tions: “surprise” and “indignation”. Surprise is the intel-
lectual emotion when we see something happening against 
expectation: a patient with an unusual exposure, unusual 
disease manifestation, sudden cure, or sudden ill-understood 
deterioration; a laboratory result that is an anomaly; and a 
sudden epidemic of disease in a population. Indignation is 
the moral emotion: a group of patients is not being treated 
well because we lack sufficient knowledge, or because we are 
blundering in organizing health care or in transmitting and 
applying public health knowledge. Some passion is useful 
to bring any undertaking to a good end, be it that the passion 
should be restrained and channeled into polite undertakings, 
like in a research protocol. While doing the research project, 
maintaining some of the original passion will help you to find 
ways to overcome the daily hassles of research, the misadven-
tures, the difficulties of getting others to collaborate, and the 
difficulties of getting published (Appendix Example A11).
Sharpening the research question: 
the pruning 
Pruning a research question means cutting away anything that 
is unnecessary, so that only the essence remains. 
The initial spark of an idea will usually lead to some rather 
general research question. Invariably, this is too ambitious, or 
so all-encompassing that it cannot be researched (at least not 
within the time frame of a single grant or PhD project). You 
have to refine your research question into something that is 
interesting, yet feasible. To do so, you have to know clearly 
where you are heading. The emphasis on a clear preconceived 
idea about what you want to attain by your research often comes 
as a surprise; some people object: “[…] isn’t research about dis-
covery? How can you know in advance what you want to find?”
The social scientist Verschuren proposed the “wristwatch 
metaphor”.20 A researcher is not like a beachcomber, who 
strolls along the beach to see whether anything valuable 
washed ashore. Rather, a researcher is like someone who has 
lost her wristwatch on the beach and returns to search for it. 
She knows what part of the beach to look, she can describe 
her wristwatch in detail, and once she has found it, she knows 
that this is the watch she was looking for. Some further back-
ground to these ideas can be found in Appendix B. 
Charles Medawar wrote in his Advice to a Young Scientist 
(page 18)21 that as much as politics is the ‘art of the possible’, 
research is the ‘art of the soluble’. A research question should 
be limited to a question that can be solved with the resources 
at hand. This does not mean that you should preferentially 
study “trivial” questions with easy solutions. It does mean 
that you should seek out your particular niche: something 
specific, something that was overlooked by others, or some 
new twist to a general question, so that you can make your 
own contribution.
The concept of “serendipity” is often invoked when think-
ing of “seeking novelty”: it means finding something that 
you were not looking for. For a full discussion of the more 
complex reality that shows how, in reality, “chance favors a 
prepared mind”, see Appendix C.
Proceed in the inverse order of the paper 
that you will write
From the aforementioned, we know that we need a precise 
aim and a soluble research question.
How can we achieve this? The best approach is to “begin 
at the end”, that is, the conclusion that you hope to support 
when you eventually publish your research findings, perhaps 
many years from now.22 Most medical research papers have 
a fixed format: introduction, methods, results, discussion. 
Usually, the discussion has three parts: summary of the 
results, discussion of the strengths and limitations, and the 
importance and interpretation of the findings. There you start: 
you try to imagine what such last lines of the eventual paper 
might be – in particular what their intent, their message to the 
reader might be. Another useful strategy would be to imagine 
what might be written in the separate box “What this paper 
adds” that many journals nowadays ask to convey the mes-
sage from the authors clearly and succinctly to the readers. 
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The “latent” versus the “stated” objective
The pioneer clinical epidemiologist Feinstein wrote that a 
good research consultant should be like a good clinician, 
who first wants to learn from the patient: “What is the chief 
complaint?”, that is, which is the problem that you want to 
study. Next, “What will you do with the answer?”22 The lat-
ter question is not just about the potential conclusions of the 
research paper, but more importantly, their meaning. What 
is the intended effect (or impact) of the findings? He called 
this the “latent objective”: what do you want to achieve or 
change by your project; the “stated objective” is different, it 
is the type of result that the study will deliver. For example, 
the stated objective can be that you want to do a randomized 
trial to compare one intervention versus another and that 
you will look at recurrence of disease. The latent objective 
might be that you are concerned that one intervention may 
be harmful to patients, driven by special interests, and that 
if this is the case it should be abolished. 
Rather analogously, the long-time editor of the Annals of 
Internal Medicine, Edward Huth, proposed in his book about 
medical publishing the “So-What” and the “Who-Cares” 
tests: “What may happen if the paper’s message is correct?”; 
may it change concepts and treatment or stimulate further 
exciting research?23 In fact, many funders now require such 
an “impact statement” as part of the grant application process.
Experienced research consultants know that when trying 
to discover the latent objective, it is useful to brush aside the 
detailed protocol and to ask directly what the meaning of the 
research is. The meaning of the research is often not clearly 
stated in a formal study protocol that limits itself more or 
less to “stated aims”.24 Like a patient who cannot articulate 
her/his complaints very well, would-be researchers lose 
themselves in trivial “side issues” or operational details of 
the protocol. Appendix Examples A2 and A11 explain the 
importance of elucidating the underlying frustration of the 
clinician-researcher to clearly guide a research effort. 
After initial questions have set the scene and clarified the 
“latent objective” of a project, the next questions are more 
operational, translating the latent objective back into a “stated 
objective”.22 The stated objective should be a feasible research 
project. According to Feinstein, one should ask: what maneuver 
is to be executed (what intervention, deliberate or not, and how 
is it administered), what groups are to be compared (and why 
those groups), and what is the outcome that we will study? 
In these phases of discussion, one needs to immerse one-
self into the problem: one has to understand it biologically 
and clinically, and how it is dealt with in the daily practice 
of health care in the setting in which you will do research. 
Getting deeply immersed in the problem is the only way of 
arriving at shrewd or new solutions for studies on vexing 
medical or public health problems (Appendix Example A9). 
Mere discussion of technical or procedural aspects of a pro-
posed design, data collection, or analysis will usually not 
lead to new insights.
Specific pruning questions, to ask yourself 
or others
In initial discussions, one goes back and forth between the 
general aim (the latent objective), the scientific questions 
that follow from it, and the possible research designs (with 
stated objectives). After feeling secure about the “latent” aim, 
proceed with more specific questions. 
•	 Try to describe exactly the knowledge gap that you 
want to fill (ie, the watch that you lost at the beach). Is 
it about etiology, about pathogenesis, about prognosis? 
What should change for the benefit of a particular group 
of patients? Try to be as specific as possible. Do your 
colleagues see these problems and their solutions as you 
do? – and if not, why don’t they?
•	 Once you know the point you want to make, describe 
what table or figure you need to fill the gap in knowledge, 
that is, what would your results look like? This means 
drawing a simple table or graph. Are these the data you 
want? Will these tables convince your colleagues? What 
objections might they have? Keep in mind that if the 
research results go against ingrained beliefs, they will be 
scrutinized mercilessly, so the important aspects of your 
research should be able to withstand likely objections.
•	 Thereafter, the questions become more practical: what 
study design is needed to produce this table, this figure? 
Can we do this? Do we have the resources or can we find 
them?
Be self-critical
You should always remain self-critical about the aspects that 
threaten the validity of your study (Appendix  Example A12).25 
If the practical problems are too large, or the research ques-
tion too unfeasibly grandiose, it might be wise to settle for a 
less ambitious aim (Appendix Example A13). 
Paraphrasing Miettinen,26 the first decision is whether you 
should do the study at all. There might be several reasons to 
decide not to pursue a study. One might be that arriving at a 
satisfactory design will be impossible, because of biases that 
you are unable to solve. It serves no purpose to add another 
study that suffers from the same unsolved problems as 
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 previous studies. For example, it does not serve any purpose to 
do yet another study that shows lower mortality in vegetarians, 
if you cannot solve the problems of confounding that vegetar-
ians are persons who have different lifestyles in comparison 
with others.27 (If, however, you have found a solution – pursue 
it at all means!) Nevertheless, thinking about the potential 
problems and ultimate aims of a seemingly impossible ques-
tion can foster the development of a new study design or a 
new method of analysis, (Appendix Examples A2, A9, and 
A10). In the same vein, deciding that you cannot do a study 
yourself might make you look for collaboration with persons 
who have the type of data that you do not, for example, in a 
different population where it is believed that confounding is 
not so severe or may even be in the opposite direction.
All studies have imperfections, but you need to be aware 
which ones you can tolerate.28 In the early stages of an enquiry, 
an “imperfect” study might still be worthwhile to see whether 
“there might be something in it”. For example, time trends or 
ecological comparisons are often seen as poor study designs to 
assess causality by themselves, but they can be very valuable 
in helping to develop ideas, as well as providing a “reality 
check” about the potential credibility of some hypothesis.29 
Conversely, it is pointless to add yet another study, 
however perfect, showing what is already known very well – 
unless you have to do it for “political” purposes, say, for 
convincing decision makers in your own country. 
Finally, it is not a good use of your time to chase 
something completely improbable or futile. For example, 
at the present state of the debate, it serves no purpose to 
add another study about the presence or absence of clinical 
benefits or harms of homeopathy: no one will change his or 
her mind about the issue.30,31 An exception might be some-
thing that is highly improbable, but that if true might lead to 
completely revolutionary insights – such an idea might be 
worth pursuing, even if the initial reaction of outsiders might 
remain incredulousness. Still, you should pursue unlikely 
hypotheses knowingly, that is, with the right amount of self-
criticism – in particular, to make yourself aware when you 
are in a blind alley. 
To keep yourself on the “straight and narrow”, it helps 
to form a group of people who cover different aspects of 
the problem you want to study: clinical, biochemical and 
physiological, and methodological – to discuss the project 
as equals. Such discussions can not only be tremendous fun 
but also will invariably lead to more profound and diverse 
research questions and will help to find solutions for practical 
as well as theoretical problems. In the right circumstances of 
a “machtsfreie Dialog”32 (a communication in which all are 
equal and that is only based on rational arguments and not on 
power – which all scientific debates should be), such a circle 
of colleagues and friends will help you to be self-critical. 
Finally, when pursuing one’s research interests, one 
should be prepared to learn new skills from other fields or 
collaborate with others from these fields. If one stays only 
with the techniques and skills that one knows, it might not 
lead to the desired answers.33
What if the data already exist? And you 
are employed to do a particular analysis 
with an existing protocol?
Even in the circumstance that the data already exist, it greatly 
helps to not jump into an analysis, but to think for yourself 
what you would ideally like to do – if there were no con-
straints. As Aldrich mentioned,19 also in that circumstance 
researchers should still
[…] begin their literature review and conceptual modeling 
as if they had the luxury of a blank slate […]. Writing with-
out data constraints will, I believe, free their imaginations 
to range widely over the realm of possibilities, before they 
are brought to earth by practical necessities.
Moreover, this will make clear what compromises one 
will make by accepting the available data and the existing 
analysis protocol. Otherwise, one starts an analysis without 
being sufficiently aware of the limitations of a particular 
analysis on particular data. 
The difference between explanatory and 
pragmatic research
A useful distinction is between explanatory and pragmatic 
research: the former is research that aims at discovery and 
explanation, whereas the latter is intended to evaluate inter-
ventions or diagnostic procedures. The first type of research 
consists of chasing explanations by pursuing different and 
evolving hypotheses; the second type of research aims at 
making decisions about actions in future patients.27 The two 
opposites differ strongly in their thinking about the types of 
studies to pursue (eg, observational vs randomized), about 
the role of prior specification of a research hypothesis, about 
the need for “sticking to a prespecified protocol”, and about 
subgroup analyses and multiplicity of analyses. Some of these 
will be explained in the following subheadings.
The difference between explanatory and pragmatic trials 
is sometimes thought to mirror the difference between doing 
randomized trials versus observational research. However, 
even for randomized trials, a difference exists between 
“ pragmatic” and “explanatory” trials (coined first by Schwartz 
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and Lellouch).34 Because it is not always easy to delineate what 
aspects of a randomized trial are “pragmatic” or “explana-
tory”, instruments have been crafted to help researchers and 
evaluators.35,36 Conversely, not all observational studies are 
explanatory: some are needed for pragmatic decisions (think 
about adverse effects of drugs and also about diagnostic evalu-
ations where studies should influence practice guidelines) 
– while other studies aim at explaining how nature works. 
Which iterations should you allow 
yourself? Anticipating the next project
Thinking about a research problem is a strongly iterative 
process.2,33,37 One starts with a broad aim and then tries out 
several possible ideas about studies that might lead to better 
understanding or to better solutions. 
Likewise, project proposals characteristically go through 
many iterations. In the early phases of the research, it is com-
monplace that the study design or even the research question 
is changed. Specific suggestions about common research 
problems and their potential solutions were given by Hulley 
and Cummings,2 which we reproduce in Appendix D. 
The revision of the aims of a project may be profound, in 
particular in explanatory research (see “The difference between 
explanatory and pragmatic research” section), in contrast to 
pragmatic research  (see “Shouldn’t you stick to a predefined 
protocol?” section). The chemist Whitesides wrote: “Often 
the objectives of a paper when it is finished are different from 
those used to justify starting the work. Much of good science is 
opportunistic and revisionist”.38 Along a similar line, Medawar 
proposed that to do justice to the real thought processes of a 
research undertaking, the discussion section of a paper should 
come at the beginning, since the thought processes of a scientist 
start with an expectation about particular results. The expecta-
tion determines which findings are of interest and why they 
will be interpreted in a particular way.6 He added that in real 
scientific life, scientists get new ideas (ie, new expectations) 
while doing their research, but “[…] many of them apparently 
are ashamed to admit, that hypotheses appear in their mind 
along uncharted byways of thought”.6 
“Seeing something in the data” can be an important part of 
scientific discovery. This is often decried as “data dredging”, 
which it is not: one sees something because of one’s back-
ground knowledge and thereby there always is some “prior” 
that exists – even if that was not specified beforehand in the 
study protocol.27,39 The word “exploratory” is often misused 
when it is used to characterize a study. True “exploratory” 
data analysis would only exists if it is mindlessly done, such 
as a Genome Wide Association Study (GWAS) analysis – but 
even GWAS analyses have specific aims, which becomes 
clear when results are interpreted and some findings are des-
ignated as “important” and others not. As stated by Rothman:
Hypotheses are not generated by data; they are proposed by 
scientists. The process by which scientists use their imagina-
tion to create hypotheses has no formal methodology […]. 
Any study, whether considered exploratory or not, can serve 
to refute a hypothesis.40
Appendix Examples A5 and A7 show how projects 
changed mid-course because of a new discovery in the data 
or in the background knowledge about a research topic. 
Generally, it is a good habit to think through what the 
next project might be, once you will have the result of the 
project you are currently thinking about, so as to know what 
direction your research might take.33 
Shouldn’t you stick to a predefined 
protocol?
Different research aims, in particular along the “explanatory” 
versus “pragmatic” continuum, may lead to different attitudes 
on the amount of change that protocols may endure while doing 
research.27,39 For randomized trials, and also for pragmatic 
observational research, the research question is usually fixed: 
does a new therapy lead to better outcomes for a particular 
group of patients in a particular setting? Because findings from 
randomized trials or pragmatic observational research may 
lead to millions of patients to adopt or avoid a particular 
therapy (which means that their well-being or even life 
depends on the research) researchers are generally not at 
liberty to change their hypotheses at the last moment – for 
example, by suddenly declaring an interest in a particular 
subgroup. They should stick to the predefined protocol. If a 
change is needed for practical reasons, it should be clearly 
stated in the resulting publications. This makes thinking about 
research questions and doing pilot studies beforehand all the 
more important (see “Pilot Study” section). 
In contrast, much epidemiologic and clinical research 
tries to explain how nature works. This gives greater leeway: 
exploration of data can lead to new insights. Thus, “sticking 
to the protocol” is a good rule for randomized trials and prag-
matic observational research, but may be counterproductive 
for explanatory research.39,41 Nevertheless, it is good to keep 
track of the changes in your thoughts and in the protocol, 
even if only for yourself. In practice, many situations are 
intermediate; in particular when using large available data 
sets, it often happens that one envisages in a protocol what 
one would do with the data, only to discover upon opening 
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the data files that the data fall short or are more complex than 
imagined; this is another reason for doing pilot studies, even 
with large available data sets (see “Pilot Study” section).
How much literature should you read? 
If you are setting up a new research project in a new area, 
do not start by reading too much. You will quickly drown in 
the ideas of others. Rather, read a few general reviews that 
identify unanswered problems. Only return to the literature 
after you have defined your research question and provision-
ally your study design. Now, the literature suddenly becomes 
extremely interesting, since you know what types of papers 
you need. You also know what the potential objections and 
shortcomings are of the different design options, because 
you thought about them yourself. The number of relevant 
papers usually greatly shrinks, see Appendix Example A4. 
Shouldn’t you do a systematic review 
first? 
It is argued that before embarking on a new piece of research, 
one should first do a systematic review and/or meta-analysis, 
because this may help to define the gaps in knowledge more 
precisely, and guide new research – or may show that the 
question has been solved. This argument is somewhat circular. 
A systematic review is a piece of research in itself, intended 
for publication, and requires much time and effort. Like any 
piece of research, it requires a clear research question. As 
such it does not “identify gaps”: a systematic review is about 
a research question which is already specified, but for which 
more information is needed. Thus, the main function of the 
advice to first do a systematic review is to know whether the 
research question that one has in mind has not yet been solved 
by others. Perusing the literature in depth is absolutely needed, 
for example, before embarking on a randomized trial or on 
a major observational study. However, this is not the same 
as doing a formal systematic review. In-depth scoping of the 
literature will suffice. If it is found that potentially valuable 
studies already exist on the research question that one has in 
mind, then the new study that one is thinking about may be 
discarded, and a systematic review should be done instead. 
Intermezzo: specific schemes to 
structure reasoning
Specific schemes have been proposed to guide our reasoning 
between the stage of delineation of the “gap in knowledge” 
and the stage of proposing the research design. 
The acronym FINER (feasible, interesting, novel,  ethical, 
and relevant) was coined by Hulley and Cummings2 and 
denotes the different aspects that one should consider to 
judge a budding research proposal. These words are a good 
checklist for an in-depth self-scrutiny of your research. The 
central aspects are the feasibility and whether the possible 
answers are exciting (and/or much needed).
The PICO format (Patient, Intervention, Control or 
Comparison, Outcome) is advocated by the evidence-based 
medicine and Cochrane movements and is very useful 
for clinical therapeutic research, particularly randomized 
controlled trials (RCTs).1,42 Questions about therapeutic 
interventions are highly specific, for example, a particular 
chemotherapeutic scheme (the intervention) is proposed 
to study survival (the outcome) among young women with 
a particular form of stage III breast cancer (the patients). 
This framework is less useful, and becomes a bit pointless, 
for etiologic research about generalizable questions such 
as: “Does smoking cause lung cancer?” which applies to 
all humans and to different types of smoking. Of course, 
all research will be done in particular population, with par-
ticular smoking habits, but this does not necessarily define 
the research question. Some of the first investigations about 
smoking and lung cancer were done in male doctors aged 
≥35 years in the UK43 – this was a very convenient group 
to research, but being a male doctor in the UK is not part 
of the research question. 
The PICO format is thus most applicable for pragmatic 
research. A much more detailed and elaborate scheme for 
pragmatic research was proposed by the US Patient-Centered 
Outcomes Research Institute (PCORI) which has published 
Methodology Standards, including “Standards for Formulat-
ing Research Questions”. While we would not agree with 
all six standards, junior investigators may find the structure 
useful as they think through their options – especially for 
pragmatic research questions.44
Counterfactual reasoning3 emphasizes those aspects of 
the “ideal randomized trial” that should be mimicked by an 
observational study. A key question is whether your study 
is addressing a hypothesis that could in theory be studied in 
a randomized trial. For example, if the research question is 
“does smoking cause lung cancer?”, then this is a question 
that could in theory (but not in practice) be addressed by 
randomizing study participants to be smokers or nonsmokers. 
In this situation, it may be useful to design your observa-
tional study with the intention of obtaining the same answer 
that would have been obtained if you had been able to do a 
randomized trial. 
However, the aims of explanatory observational research 
are different from those of randomized trials.27 Explanatory 
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research about disease etiology may involve “states” like being 
female, being old, being obese, having hypertension, having a 
high serum cholesterol, carrying the BrCa1 gene, and so on, 
as causes of disease. None of these causes are interventions. 
In contrast, RCTs focus on what to do to change particular 
causes: which interventions are feasible and work? For exam-
ple, being female might expose a person to job discrimination; 
the intervention might be to have women on the appointment 
committee or to use some kind of positive discrimination. 
Likewise, the gene for phenylketonuria leads to disease, but 
the intervention is to change the diet. For carriers of BRCa1 
genes, different strategies can be evaluated in RCTs to evalu-
ate their effectiveness in preventing premature death due to 
breast cancer: frequent screening, prophylactic mastectomy, 
hormone treatment, and so on – which may have different 
effects. For obesity or hypertension or hypercholesterolemia, 
different types of interventions are possible – with potentially 
different effects and different adverse effects. 
The interventionist outlook, that is, trying to mimic an 
RCT, can be very useful, for some type of observational stud-
ies, for example, about the adverse effects of drugs. It helps to 
make certain that one can mimic an “intervention” (ie, patients 
starting to use particular drugs) that is specific and consistent 
in groups of patients that are comparable (more technically, 
exchangeable – meaning that the results of the investigation 
would not change if the persons exposed and nonexposed were 
swapped). These conditions can be met in a credible way, if there 
are competing drugs for a similar indication, so that there is 
an active drug comparator: the interventions (use of different 
drugs in different patients) will be well defined, and the patients 
on the different drugs will tend to be comparable. This works 
particularly well if you are focusing on adverse drug effects that 
were unknown or unpredictable at the time of prescription.45,46 
For example, you may obtain more valid findings in a study that 
compares the adverse effects of two different beta agonists for 
asthma care (ie, two different drugs within the same class), than 
to design a study which compares patients who are prescribed 
beta agonists with patients who are prescribed other asthma 
medication, or no medication at all – because the latter might 
be a highly different group of patients.47 
As mentioned, there are some important studies about 
causes of diseases where a randomized trial is not feasible, 
even in theory. In particular, there are various “states” which 
are major causes of disease (obesity, cholesterol, hyperten-
sion, diabetes, etc). These states strongly affect the risks of 
disease and death, but cannot be randomized. For example, it 
is difficult to conceive of randomizing study participants to be 
obese or not obese; however, we could randomize them for the 
reduction of obesity, for example, through exercise, but such 
a study would assess the effects of a particular intervention, 
not of obesity itself. Still, it remains important to estimate 
the overall effects of obesity, that is, to answer the question 
“would this group of people have had different health status, 
on the average, if they had not been obese”. In this situation, 
the concept of “interventions” is not relevant to designing 
your study (at least in the way that the term “intervention” 
is commonly used). What is more relevant is simply to focus 
on the counterfactual contrast which is being assessed (eg, a 
body mass index [BMI] of 35 versus a BMI of 25), without 
specifying how this contrast came about. 
A technique that has gone hand in hand with counterfac-
tual reasoning in epidemiology is drawing DAGs; several 
introductions to DAG theory can be found in epidemiologic 
textbooks.3,48 DAGs can be useful in the brainstorming phase 
of a study, after the general research question has been 
defined. At this stage, a general structure for the study is 
envisaged and the complexity of the causal processes needs 
clarification. A DAG can be extremely useful for illustrating 
the context in which a causal question is being asked, the 
assumptions that will be involved in the analyses (eg, whether 
a particular risk factor is a confounder, a mediator, or a col-
lider), and help us question the validity of our reasoning.49 
Using DAGs helps us also decide which variables we need 
to collect information on and how they should be measured 
and defined. Given that DAGs root in causal thinking, their 
construction is, of necessity, subjective.
Preparation: pilot study, protocol, 
and advance writing 
Doing a pilot study and collecting 
ancillary information about feasibility
May I now start? is a question heard after lengthy delibera-
tions about the research question and the potential studies that 
follow from it. Such deliberations almost invariably produce a 
lot of enthusiasm and exhilaration – because they are fun. The 
researcher wants to begin collecting data or start the analysis. 
However, Crombie and Davies, in their chapter about “Devel-
oping the research question” state emphatically: “Don’t rush 
into a study”.16 Separate from doing a pilot study, which is 
about the procedures of your study, you may also need to col-
lect ancillary information before actually starting your study.
Pilot study
Even if you think you are totally certain of what you want, 
you should first do a pilot study, based on a brief protocol.2,22 
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That initial protocol should be easy to write. You have already 
discussed the aim and design of your study. Write them down. 
You expect a particular type of information that is essential and 
that will tell the essence of your message (a particular 2-by-2 
or X-by-Y table, a particular graph), which you can describe. 
Pilot studies are not done to know the likely direction of 
the results; instead, the aim is to see whether you will be able 
to perform the procedures of your study – and ultimately 
whether that really is the study you want to do.50 The aim is 
to save yourself from embarrassment: data that very surpris-
ingly do not turn out to be what you expected, questionnaires 
that are misunderstood or do not deliver the answers that you 
need or that are not returned, laboratories that do not produce, 
patients who do not show up, heads of other departments who 
block access to their patients or materials, or yourself who 
needs more time to manage the complexity of the undertaking.
We have never heard of someone who was sorry for hav-
ing done a pilot. Conversely, we know many persons who 
found out at much personal embarrassment and institutional 
cost that their project was unfeasible. In intermediate cases, 
the pilot may show the need to change questionnaires or 
procedures before the study goes ahead.
In principle, a pilot study should be exactly like your final 
study and test out all your procedures on a small number of 
persons. Often, it is better to approach the task piecemeal and 
pilot different aspects of the research one by one. 
A tough question is how to do pilot studies and pilot 
analyses when ethical or institutional review board approval is 
necessary for some of the actions in a pilot study. One solution 
might be to avoid piloting some procedures; for example, try 
parts of the procedure – for example, you may not be able to 
randomize in a pilot, but you may be able to try out data collec-
tion procedures and forms. There is a degree of circularity about 
piloting, also in obtaining funding, as one may need funding 
for the pilot. In practice, the best step might be to ask the ethics 
committee or review board of your institute which aspects of 
the research can be piloted and under what conditions.
In Appendix E, several questions that you might ask in 
pilot studies are listed. They may lead to profound reas-
sessments of your research – particularly if you are piloting 
the collection of new data, but also if the research involves 
analyses of existing data. 
Ancillary information
It may be necessary to collect additional information about 
event rates or standard deviations of measurements to  calculate 
the statistical precision that might be obtained. Also, some-
times you need other ways of “testing the water” like proce-
dures to streamlining data collection from different centers in 
order to know whether the study is feasible. Depending on the 
study size and importance, such activities may become stud-
ies in themselves and actually take a lot of time and money. 
Advance writing of paper: before full data 
collection and/or analysis 
Whitesides’ advice is:
The key to efficient use of your and my time is that we start 
exchanging outlines and proposals as early in a project as 
possible. Do not, under any circumstances, wait until the 
collection of data is ‘complete’ before starting to write an 
outline.38
After the pilot study, you have a firm grasp of all elements 
that are necessary for a scientific paper: introduction, materi-
als and methods, results, and discussion. In the introduction, 
you explain why you have done this research. Almost always, 
an introduction comprises three ideas: what is the general 
problem? what is the particular research question? what 
study will you perform to answer that question? This is fol-
lowed by the materials and methods section. They have been 
extensively discussed and have been fine-tuned in the study 
protocol and the pilot study. Thereafter come the results sec-
tions. By now, you know what tables or figures you want and 
how you can obtain them, but not what the final numbers will 
look like. You will also have an idea about the auxiliary tables 
that you might need to explain your data to others (such as a 
table with the baseline characteristics or an additional table 
with a subgroup analysis). You can now draft the layouts of 
all these tables. Visualizing the presentation of your results 
in advance is the “bare minimum” of writing in advance. 
Finally, the discussion section. Can you write a discussion 
before you know the final data? Of course you can; you even 
must think ahead. In principle, there are only three possible 
outcomes: the study can give the results that you hoped 
for; it can show the inverse; or something indeterminate in 
between. In all instances, you can imagine how you will react. 
One possibility is that you are disappointed by the results of 
your study, and you will tend to find excuses for why it did 
not produce the results you hoped for. What excuses might 
your produce? The other possibility is that it does show what 
you wanted; then you may have to imagine how others will 
react and what their objections might be. If the results are 
indeterminate, everybody might be disappointed, and you will 
need to explain the failure of your research to give clear-cut 
results. When you detect a specific weakness by imagining 
this situation, you may wish to change aspects of your study. 
As we explain in Appendix F, there is no need to write a 
very extensive paper as a first draft – on the contrary, it might 
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be more useful to write a short paper, which has the advan-
tage that others will more readily read it and comment on it. 
Never be afraid to discuss your study at all stages 
extensively with others, not only your immediate research 
colleagues but also semi-outsiders and also in this advance-
writing stage. If you know, or are told by others, that a par-
ticular direction of your results might not be believed and 
therefore draw criticism because of some potential deficiency 
in your study, why not remedy it at this stage? Looking at 
what you have written, or by discussing potential results with 
others, you will be able to imagine more clearly what your 
readers and critical colleagues might object to. 
Writing a paper beforehand is the ultimate test of whether 
the research project is what you wanted, whether your rea-
soning flows logically, or whether you forgot something. The 
initial draft will be a yardstick for yourself and for others – 
whatever happens during the course of your research. This 
will help you to surmount surprise happenings: you have 
written down where you started and why, and therefore you 
will also know very securely when and why you have to take 
a detour – or even a U-turn. 
Writing is difficult and time-consuming. Writing a paper 
can easily take 5–10 revisions, which might span a full year 
(inclusive of the time it takes your supervisor or your col-
leagues to produce comments). During the writing, you will 
often be obliged to go back to the data and do additional or 
different analyses. Since your paper will need many revisions, 
and this will take such a long time, why not take a head-start 
at the beginning of your data collection? It will save frustra-
tion and lost time at the end of your project.
Many guidelines and advices exist about writing, both 
about the substance (how to use words and phrases) and 
about the process. All beginning researchers should have a 
look at some books and papers about writing, and seasoned 
researchers can still profit from rereading them. Several 
reporting guidelines exist for several types of studies (RCTs, 
observational, diagnostic research, etc). They are often very 
detailed, in describing what should be in title, abstract, and 
so on. Although they should not be mechanically adhered 
to,28 they help writing. In Appendix F, we have collected 
some wisdom that we particularly liked; several books on 
writing are listed, as well as reporting guidelines that help 
researchers to craft papers that are readable and contain all 
the information that is necessary and useful to others. 
Now you can start “your research”
After the piloting and after having written your paper, you are 
ready to start your data collection, your analysis, or whatever 
is needed to “do your research”.
The work that is needed before you can start to “do your 
research” will take a great deal of time and effort. What 
will you have achieved after setting up a piece of research 
following the lengthy and involved precepts of this paper? 
You will have specified a limited research question that you 
will solve. You will add one little shining stone to the large 
mosaic of science. At the time that you do the study, you may 
still be too close to see its effect on the overall picture. That 
will come over the years. 
Further reading
Some texts that we mention in the paper might be especially 
worthwhile for further reading; see Appendix G.
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